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Influence of carbonate on the complexation of
Cm(III) with human serum transferrin studied by
time-resolved laser fluorescence spectroscopy
(TRLFS)
Nicole Bauer*ab and Petra J. Panakab
The complexation of Cm(III) with transferrin is investigated in the pH range from 3.5 to 11.0 in the absence
of carbonate and at c(carbonate)tot = 25 mM. In the absence of carbonate two Cm(III) transferrin species I
and II are formed depending on pH. An increase of the total carbonate concentration favors the formation
of the Cm(III) transferrin species II with Cm(III) bound at the Fe(III) binding site of transferrin at significantly
lower pH values. The spectroscopic results directly prove that carbonate acts as a synergistic anion for
Cm(III) complexation at the binding site of transferrin. At c(carbonate)tot = 25 mM the formation of the




3 are formed successively with increasing pH. The formation of
Cm(III) carbonate species results in a decreased fraction of the Cm(III) transferrin species II at pH Z 7.4
which indicates that carbonate complexation is an important competition reaction for Cm(III) transferrin
complexation at physiological carbonate concentration.
Introduction
If radionuclides are accidentally released into the environment,
in particular actinides can cause a serious health risk upon
incorporation. Since they have no essential function in the
human body there is only deficient knowledge about the
biochemistry of actinides in man. With regard to the develop-
ment of potential decontamination therapies, a detailed under-
standing of the mechanisms of relevant biochemical reactions
is required.1
One potential reaction that incorporated actinides might
undergo is the coordination to human serum transferrin.
Transferrin is an iron carrier protein in blood with a molecular
mass of 79 570 Da and consists of 679 amino acids.2–4 The
ternary structure of transferrin is characterized by folding into
two similar lobes which are joined by a short peptide chain.5
Each lobe consists of a/b-subunits and is divided into two
domains separated by a cleft housing the metal binding site
for Fe(III). The coordination of Fe(III) and the synergistic anion
leads to a conformational change of transferrin from an open to
a closed form. This structural change stabilizes the metal ion
transferrin complex and is important for its recognition by the
receptor.2,6
In both lobes Fe(III) is coordinated by two tyrosines, one
aspartate, one histidine and the synergistic anion in a distorted
octahedral geometry.7,8 Under physiological conditions the
synergistic anion is carbonate. It is required for the complexa-
tion of metal ions to transferrin since neither the anion nor the
metal ion are bound strongly in the absence of the other (except
for VO2+).9 Carbonate coordinates to Fe(III) in a bidentate mode
and is linked to the protein by hydrogen bonding which leads to the
formation of a very stable metal Fe(III)–carbonate–transferrin ternary
complex.7,8 Furthermore, complexation of the synergistic anion
reduces the positive charge of the protein which originates from
an arginine sidechain and a helix N-terminus directed towards the
binding site. This facilitates the coordination of a positively charged
metal ion.2 Additionally, protonation of the carbonate anion may
also play a role in iron release during endocytosis.2,10
Besides carbonate, other anions like oxalate, malonate,
glycolate or lactate can also act as synergistic anions and form
Fe(III)–anion–transferrin ternary complexes.11,12 These are typically
much weaker than the respective complexes with carbonate and
most of them are observed only under carbonate free conditions.
The key structural feature of these anions is the presence of a
carboxylate group and a proximal functional group within 6.3 Å in a
‘‘carbonate-like’’ conformation.11
In blood serum transferrin is about 30% saturated with iron.
Consequently, non-saturated transferrin is available for the
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complexation of other metal ions. Besides ferric iron about 30
other metal ions were identified to bind to transferrin, among
them are actinides like Th(IV), Pa(V), U(VI), Np(IV), Np(V), Pu(IV),
Am(III) and Cm(III).13–24 The complexation of Cm(III) with trans-
ferrin was studied in the pH range from 3.5 to 11.0 at ambient
carbonate concentration.19,24 Two different Cm(III) transferrin
species were identified and characterized depending on pH. At
pH Z 7.4 Cm(III) is bound at the Fe(III) binding site of
transferrin whereas at lower pH a nonspecific Cm(III) transferrin
species is formed.24 Stability constants for the N- and C-lobe of
Cm2Tf were determined experimentally to be logKC = 8.8  0.3
and logKN = 7.0  0.1 (pH 8.6), respectively.19
In the present work we investigate the influence of the
carbonate concentration on the Cm(III) transferrin complexation
using time-resolved laser fluorescence spectroscopy (TRLFS). To
date all measurements with Cm(III) and transferrin are performed
at ambient carbonate concentration. Since carbonate acts as a
synergistic anion for Fe(III) complexation at the binding sites it is
also of particular interest to study the impact of carbonate on the
formation of the Cm(III) transferrin species I and II. Therefore,
fluorescence spectra of Cm(III) transferrin in the pH range from 3.5
to 11.0 in the absence of carbonate and at physiological carbonate
concentration are measured at room temperature as well as at
physiological temperature to get information on the influence of
carbonate on the Cm(III) transferrin interaction.
TRLFS is a very sensitive method to study complexation
reactions of lanthanides and actinides in the submicromolar
concentration range.25 Cm(III) is used as a representative for
trivalent actinides because of its excellent fluorescence properties.26
Spectroscopic parameters like shape and position of the emission
bands provide information on the coordination environment of the
metal ion and the complex geometry.
Experimental section
Chemicals and sample preparation
The protein samples were prepared in TRIS (Amresco) buﬀered
solutions (10 mM, pH 7.4) with a physiological sodium chloride
medium of 150 mM NaCl (Merck Millipore) using ultrapure
water (Millipore, Billerica, MA, USA; 18.2 MO cm). The ionic
strength of the samples is determined by the concentration of
NaCl and fixed at I = 0.16 m. Human serum apo-transferrin of
high reagent grade (apo-transferrin human, 98%) was purchased
from Sigma. It was purified using size exclusion chromatography
(Sephadex G-25 medium, GE Healthcare) followed by filtration
(Amicon Centrifugal Filter Units, 30 kDa) before use according
to the protocol of Harris et al.27,28 The protein concentration of
the transferrin stock solution was determined by UV/Vis
spectroscopy at l = 280 nm using an extinction coeﬃcient of
e = 93 000 M1 cm1.29
The Cm(III) stock solution used for the TRLFS studies
(c(Cm) = 3.33  106 M in 15.7 mM HClO4) had an isotopic
mass distribution of 89.7% Cm-248, 9.4% Cm-246, r 1%
Cm-243, Cm-244, Cm-245 and Cm-247. The Cm(III) concentration
of the TRLFS samples was fixed at 1.00  107 M by adding 30 ml
of the Cm(III) stock solution to 970 ml of a buﬀered transferrin
solution with a concentration of 4.85  106 M resulting in a
final transferrin concentration of 5.00  106 M. Complexation
studies were carried out at varying pH values between 3.5 and
11.0 using NaOH and HCl solutions (Merck Millipore) of diﬀerent
concentrations (1.0 M, 0.5 M, 0.1 M, and 0.01 M) for adjustment.
Unless stated otherwise the pH was adjusted starting from pH 11
downwards to pH 3.5. TRLFS measurements were performed at
room temperature (296 K) and physiological temperature (310 K).
For measurements in the absence of carbonate the purified
transferrin stock solution was degassed using seven freeze–
pump–thaw cycles. The sample preparation and the adjustment
of the pH was performed in an argon glove box using degassed
solvents and chemicals, exclusively. For the measurements at
physiological carbonate concentration the samples were pre-
pared with TRIS buffer containing 150 mM NaCl and 25 mM
NaHCO3 (Sigma-Aldrich).
Time-resolved laser fluorescence spectroscopy
TRLFS was performed using a Nd-YAG (Continuum Surelite Laser)
pumped dye laser system (NARROWscan D-R Dye Laser) with a
repetition rate of 10 Hz. For excitation of Cm(III) a wavelength of
396.6 nm was used. Emission spectra were recorded in the range of
580 to 635 nm after a delay time of 1 ms to discriminate short-lived
fluorescence of organic compounds. After spectral decomposition
by a spectrograph (Shamrock 303i) with a 1199 lines mm1 grating
the spectra were recorded using an ICCD camera (iStar Gen III,
ANDOR) containing an integrated delay controller. For better
comparison all spectra are normalized to the same peak area.
Results and discussion
Under physiological conditions (pH 7.4, T = 310 K,
c(carbonate)tot = 25 mM, c(NaCl) = 150 mM) Fe(III) is complexed
by four amino acids and a bidentate coordinating carbonate at the
binding site of transferrin.7,8 Although we suppose the coordina-
tion environment of the Cm(III) transferrin species II to be
similar to the Fe(III) transferrin complex the TRLFS data provide
no direct information on the nature of the synergistic anion. In
principle, carbonate or bicarbonate could act as a synergistic
anion for Cm(III) transferrin complexation. In a closed system
with a total carbonate concentration of c(carbonate)tot = 25 mM
the concentrations of CO3
2, HCO3
 and CO2(aq) depending on
pH (Fig. 1) are calculated from the logK values of the carbonate
equilibria which have been taken from the Thermodynamical
Database of the Nuclear Energy Agency (NEA – TDB) and extra-
polated to I = 0.16. CO2(aq) dominates in the acidic pH range up
to pH 6.0. With increasing pH the bicarbonate concentration
increases. HCO3
 is the dominating species between pH 6.2
and 9.8. Carbonate is formed at pH Z 7.4 and dominates the
speciation above pH 9.8. In the present study the influence of
carbonate on the complexation of Cm(III) with transferrin is
investigated with dependence on pH. The total carbonate
concentration, which means the total concentration of the
species CO3
2, HCO3
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For reasons of simplicity, total carbonate concentrations of
c(carbonate)tot = 0.23 mM and c(carbonate)tot = 25.00 mM are
referred to as ‘‘ambient carbonate concentration’’ and ‘‘physio-
logical carbonate concentration’’ with the speciation of CO3
2,
HCO3
 and CO2(aq) depending on the pH.
Complexation of Cm(III) with transferrin in the absence of
carbonate
Complexation of Cm(III) with transferrin as a function of pH
was studied under carbonate free conditions at room tempera-
ture (296 K). At each pH step a fluorescence spectrum was
recorded. The normalized fluorescence spectra in the pH range
from 4.0 to 10.5 are shown in Fig. 2. The spectra display a strong
pH dependency of the complexation reaction. Up to pH 6.0 the
system is dominated by the Cm(III) aquo ion (lmax = 593.9 nm).
30–32
A further increase of pH leads to the successive formation
of two Cm(III) transferrin species with emission maxima at
lmax = 599.8 nm and lmax = 619.9 nm, respectively. The
spectrum of the second Cm(III) transferrin species is characterized
by a hot band at lmax = 602.9 nm, which results from the
fluorescence emission from thermally populated higher ligand
field levels of the excited state.
The emission bands of both Cm(III) transferrin species formed
under carbonate free conditions are identical to those observed at
ambient carbonate concentration (c(carbonate)tot = 0.23 mM) in
our previous study.24 The emission band with lmax = 599.8 nm
corresponds to the Cm(III) transferrin species I.24 The shift of this
emission band relative to the emission band of the Cm(III) aquo
ion is 5.9 nmwhich is in the usual range of Cm(III) complexes with
various organic ligands.33–36 Furthermore, the emission band of
the Cm(III) transferrin species I is rather broad which is typical for
the formation of Cm(III) sorption species.37–40 Shape and shift of
the emission band as well as the fluorescence lifetime indicate
that this is a nonspecific Cm(III) transferrin species with five water
molecules and four additional ligands in the first coordination
sphere.24
The emission spectrum of the second Cm(III) transferrin
species is characterized by a very sharp emission band with
maxima at lmax = 619.9 nm and lmax = 602.9 nm (hot band).
This Cm(III) transferrin species II has been observed also at
ambient carbonate concentration in our previous study.24 The
bathochromic shift of 26 nm relative to the emission band of
the Cm(III) aquo ion is extraordinary and indicates strong
complexation of Cm(III) at the Fe(III) transferrin binding site.24
The fluorescence lifetime of the emission band of the Cm(III)
transferrin species II was determined to be t = 229  10 ms
under carbonate free conditions which is in very good agree-
ment with the value measured at ambient carbonate concen-
tration (t = 221  5 ms). This proves the formation of identical
species both at ambient carbonate concentration and in the
absence of carbonate. The fluorescence lifetime corresponds to
two quenching water molecules in the first coordination
sphere.19,24 Assuming an overall coordination number of nine
for Cm(III), the TRLFS results show that Cm(III) is coordinated by
four amino acids of apo-transferrin, two H2O molecules and three
additional ligands (e.g. synergistic anions like carbonate).19,24
The fluorescence spectra of the pure components (Cm(III)
aquo ion and Cm(III) transferrin species I and II) were deter-
mined from the pH dependent fluorescence spectra. They were
used for determining the fractions of the three species at
various pH values by peak deconvolution of the emission
spectra. Fig. 3 shows the species concentrations as a function
of pH (species distribution). The Cm(III) aquo ion dominates
the speciation up to pH 4.5, with the concentration decreasing
with increasing pH. The Cm(III) transferrin species I is formed
in the pH range from 4.0 to 9.7 and becomes the dominating
species between pH 4.5 and 8.5. Above pH 7.7 the concentration
of the Cm(III) transferrin species II increases continuously until
it is solely present in solution above pH 8.7.
The species distribution obtained from the measurements
in the absence of carbonate is compared to the data for Cm(III)
transferrin complexation at ambient carbonate concentra-
tion published in our previous study.24 Besides the carbonate
Fig. 1 Speciation of CO3
2, HCO3
 and CO2(aq) in a closed system at a
total carbonate concentration of c(carbonate)tot = 2.5  102 M in the pH
range between 3.5 and 11.0; T = 296 K, I = 0.16 m.
Fig. 2 Normalized fluorescence spectra of the Cm(III) transferrin
complexation in the absence of carbonate in a TRIS buﬀered solution
(10 mM) in the pH range between 4.0 and 10.5; c(Cm) = 1.0  107 M and
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concentration all experimental conditions are identical for both
studies which allows a detailed comparison. The absence of
carbonate has no significant impact on the formation of the
Cm(III) transferrin species I which confirms that carbonate is
not required for the formation of this species. In contrast,
carbonate has a distinct influence on the complexation of
Cm(III) at the Fe(III) binding site (Cm(III) transferrin species II).
At ambient carbonate concentration the complex formation
starts at pH 7.4 whereas under carbonate free conditions the
Cm(III) transferrin species II is formed at pH Z 7.7. This
indicates that carbonate acts in fact as a synergistic anion for
Cm(III) complexation at the binding site of transferrin. Hence, in
the absence of carbonate higher pH values are required for the
complexation of Cm(III) at the Fe(III) binding site of transferrin.
Although the Cm(III) transferrin samples have been prepared
under carbonate free conditions in a glove box small traces of
carbonate might still be available. Since the Cm(III) concentration
used for TRLFS measurements is very low (c(Cm) = 1  107 M)
even trace concentrations of carbonate are suﬃcient for the
formation of a ternary Cm(III)–transferrin–carbonate complex. This
might be the reason why the Cm(III) transferrin species identified
under carbonate free conditions matches the Cm(III) transferrin
species II which has been observed at ambient carbonate concen-
tration. Nevertheless, our results clearly demonstrate the positive
influence of carbonate on the complexation of Cm(III) at the Fe(III)
binding site of transferrin.
Complexation of Cm(III) with transferrin at physiological
carbonate concentration
Complexation of Cm(III) with transferrin as a function of pH
was studied at physiological carbonate concentration (25 mM)
and room temperature (296 K). The normalized fluorescence
spectra in the pH range from 3.5 to 11.0 are shown in Fig. 4. At
low pH the spectra are dominated by the emission band of the
Cm(III) aquo ion (lmax = 593.9 nm). In contrast to the measure-
ments in the absence of carbonate no emission band of the
Cm(III) transferrin species I is observed at physiological carbo-




3 with emission maxima
at lmax = 599.1 nm, 603.3 nm and 605.9 nm are formed.
41
Comparison with blank solutions (without transferrin) in the
same pH range proves that these emission bands result from
Cm(III) carbonate interaction and do not represent additional
transferrin species. Above pH 7.0 the spectra display the
increasing emission band of the Cm(III) transferrin species II
at lmax = 620.0 nm.
Fig. 5 shows the fluorescence spectra of the pure compo-




and the Cm(III) transferrin species II. They were determined
from the pH dependent fluorescence spectra of Cm(III) with and
without transferrin at physiological carbonate concentration.
The fractions of the diﬀerent Cm(III) species at various pH
values (species distribution, Fig. 6) were determined by peak
Fig. 3 Speciation of Cm(III) with transferrin in the absence of carbonate as
a function of pH in a 10 mM TRIS buﬀered solution, c(Cm) = 1.0  107 M
and c(Tf) = 5.1  106 M, T = 296 K.
Fig. 4 Normalized fluorescence spectra of the Cm(III) transferrin complexa-
tion at physiological carbonate concentration in a TRIS buﬀered solution
(10 mM) in the pH range between 3.5 and 11.0; c(Cm) = 1.0  107 M,
c(Tf ) = 5.1  106 M and c(carbonate)tot = 2.5  102 M, T = 296 K.
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deconvolution of the emission spectra using the spectra of the
pure components. The fraction of the Cm(III) aquo ion decreases
with increasing pH. In contrast to the measurements at ambient
carbonate concentration and in the absence of carbonate, the
Cm(III) transferrin species I is not formed at physiological
carbonate concentration. This again proves that it is a nonspecific
and only weakly bound Cm(III) transferrin species.
In the presence of a competing ligand like carbonate the
formation of this species is completely suppressed. Instead, the
Cm(III) mono-, di- and tri-carbonate complexes are formed
successively with increasing pH. The Cm(CO3)
+ and Cm(CO3)2

species dominate the speciation in the pH range from 5.3 to 7.2
and from 7.2 to 8.7, respectively. Additionally, up to 30% of the
Cm(CO3)3
3 complex are formed in the pH range from 7.7 to
11.0. The Cm(III) transferrin species II is formed at pHZ 7.0. In
comparison, the complex formation in the absence of carbonate
starts at a significantly higher pH value (pH 7.7). Hence, an
increase of carbonate concentration favors the formation of the
Cm(III) transferrin species at lower pH values. This confirms
again that carbonate has the function of a synergistic anion for
the Cm(III) complexation at the Fe(III) binding site of transferrin.
As shown in Fig. 6, on the one hand carbonate favors the
complexation of Cm(III) at the Fe(III) binding site of transferrin
in its function as a synergistic anion, on the other hand it is a
competitive ligand. Hence, the formation of the Cm(III) transfer-
rin species I is completely suppressed at physiological carbonate
concentration. Furthermore, carbonate complexation is also a
competitive reaction to the complexation of Cm(III) at the Fe(III)
binding site of transferrin. In the absence of carbonate the
increase of the fraction of the Cm(III) transferrin species II from
0% to 100% occurs in the pH range from 7.7 to 9.7. At
physiological carbonate concentration a significantly wider pH
range (pH 7.0–11.0) is required to form the Cm(III) transferrin
species II solely. This is attributed to the competition between
Cm(III) complexation with carbonate on the one hand and
transferrin on the other hand and has to be considered when
complexation studies with transferrin are performed under
physiological conditions. The competitive effect of carbonate
on the complexation of metal ions to transferrin has also been
observed in previous studies for some lanthanide and actinide
ions.42–45 Based on complexation studies of Gd(III) with transfer-
rin in vitro, Zak and Aisen suggest that transferrin may not be an
important carrier protein for Gd(III) in vivo because of the
formation of Gd(III) carbonate complexes.45 Taylor et al. reported
that only about 20% of Eu(III), Yb(III), Am(III) and Cm(III) are
bound to transferrin in vivo which is also attributed to the
competition with carbonate.43,44
Besides quantitative information on the speciation of Cm(III)
with transferrin at physiological carbonate concentration the
nature of the synergistic anion is of particular interest. Fig. 1
and 6 show the speciation of CO3
2, HCO3
 and CO2(aq) in a
closed system (c(carbonate)tot = 2.5  102 M) and the speciation
of Cm(III) with transferrin at a total carbonate concentration of
c(carbonate)tot = 2.5  102 M (physiological carbonate concen-
tration). Comparison depicts that the increase of the carbonate
concentration with increasing pH (black line in Fig. 1) corre-
sponds to the formation of the Cm(III) transferrin species II
depending on pH (blue line in Fig. 6). The formation of CO3
2 as
well as the Cm(III) transferrin species II starts at pH Z 7.0. The
analogy between carbonate speciation and Cm(III) complexation
at the Fe(III) binding site indicates that carbonate acts as a
synergistic anion. Furthermore, this corresponds with the fact
that bicarbonate is a very weak ligand for trivalent actinides and
lanthanides. For example the stability constants of various
lanthanide bicarbonate complexes in seawater (0.7 m ionic
strength) are in the order of logK = 1.5–1.9.46 These values are
comparable to the stability constant of CmHCO3
 which was
estimated to be logK(CmHCO3
) = 1.9  0.247,48 whereas the
stability constants of the Cm(III) carbonate complexes are signifi-
cantly higher (logK(CmCO3
+) = 8.30, logK(Cm(CO3)2
) = 13.52
and logK(Cm(CO3)3
3) = 15.52).41 The Cm(III) bicarbonate
complex has been characterized at an elevated CO2 partial
pressure of 11 bar in a 1 M NaCl solution (pH 4.4) at room
temperature. Under these conditions the formation of carbonate
complexes can be neglected. Reduction of the CO2 partial
pressure and an increase of the pH both favor the complexation
of Cm(III) with carbonate. Thus, under physiological conditions
(pH 7.4 and atmospheric pressure) the complexation of Cm(III)
with bicarbonate is insignificant. Consequently, the synergistic
anion for the complexation of Cm(III) at the binding site of
transferrin is carbonate as well as it is for Fe(III).
Complexation of Cm(III) with transferrin at physiological
carbonate concentration and temperature
In addition to the measurements at room temperature the
complexation of Cm(III) with transferrin as a function of pH
was studied at physiological carbonate concentration (25 mM)
and physiological temperature (310 K). Fig. 7 shows the normalized
fluorescence spectra in the pH range from 3.5 to 11.0. The spectra
are rather similar to those observed at physiological carbonate
concentration and room temperature.
Fig. 6 Speciation of Cm(III) with transferrin at physiological carbonate
concentration in a TRIS buﬀered solution (10 mM) in the pH range
between 3.5 and 11.0; c(Cm) = 1.0  107 M, c(Tf) = 5.1  106 M and
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They show the emission bands of the Cm(III) aquo ion, the




3 and the Cm(III) transferrin species II which are
formed successively with increasing pH.
The species distribution (Fig. 8) was obtained from the pH
dependent emission spectra by peak deconvolution using the
spectra of the pure components (Fig. 5). The Cm(III) aquo ion




3 species are formed
successively. Compared to room temperature conditions the
formation of the Cm(III) carbonate species starts at slightly lower
pH values. Above pH 6.3 the concentration of the Cm(III)
transferrin species II increases continuously until it is solely
present above pH 10.5. In comparison, at room temperature the
formation of the Cm(III) transferrin species II does not start
before pH 7.0. Hence, an increase of the temperature favors the
formation of the Cm(III) transferrin species II at lower pH values.
This is comparable to the results on the temperature dependency of
Cm(III) transferrin interaction at ambient carbonate concentration.24
In this case, the Cm(III) transferrin species II is formed at pH values
of about 0.5 units lower at physiological temperature compared to
room temperature.
Conclusions
In the present study, the influence of carbonate on the complexation
of Cm(III) with transferrin was investigated using Time-Resolved
Laser Fluorescence Spectroscopy (TRLFS). Our results show that
an increase of the total carbonate concentration favors the
formation of the Cm(III) transferrin species with Cm(III) bound
at the Fe(III) binding site of transferrin at significantly lower pH
values, which distinctively proves that carbonate acts as a
synergistic anion for Cm(III) complexation with transferrin.
Furthermore, carbonate complexation is an important competi-
tion reaction which suppresses Cm(III) transferrin complexation
significantly. At physiological carbonate concentration the formation
of the nonspecific Cm(III) transferrin species I is suppressed
completely but an increase of carbonate also has a significant
impact on the fraction of the Cm(III) transferrin species II.
Hence, the competitive eﬀect of carbonate has to be considered
when complexation studies with transferrin are performed
under physiological conditions.
Under physiological conditions (pH 7.4, T = 310 K,




3 and 15% of the
Cm(III) transferrin species II are present in solution. Results
from our previous study show the formation of about 70% of the
Cm(III) transferrin species I and 30% of the Cm(III) transferrin
species II at pH 7.4, ambient carbonate concentration and physio-
logical temperature (310 K). This again proves that carbonate
complexation is an important competition reaction which sup-
presses Cm(III) transferrin complexation significantly. Nevertheless,
15% of the Cm(III) transferrin species II are formed under physio-
logical conditions. As a consequence, the Cm(III) transferrin
complex might be recognized by the receptor followed by endo-
cytosis which could be a possible pathway for the distribution of
Cm(III) in the human body.
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